Maya Ando

CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study

Manabu Funayama, Kenji Ohe, Taku Amo et al. · The Lancet Neurology · 2015 · 359 citations

Life Sciences, Genetics, Molecular Genetics +12

(Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation

Fabienne C. Fiesel, Maya Ando, Roman Hudec et al. · EMBO Reports · 2015 · 188 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease

Asako Yoritaka, Sumihiro Kawajiri, Yorihiro Yamamoto et al. · Parkinsonism & Related Disorders · 2015 · 92 citations

Life Sciences, Neurology, Neuroscience +11

<i>VPS35</i> mutation in Japanese patients with typical Parkinson's disease

Maya Ando, Manabu Funayama, Yuanzhe Li et al. · Movement Disorders · 2012 · 92 citations · Full text

Life Sciences, Genetics, Neurology +17

The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity

Maya Ando, Fabienne C. Fiesel, Roman Hudec et al. · Molecular Neurodegeneration · 2017 · 82 citations · Full text

Life Sciences, Genetics, Molecular Biology +17